Login to Your Account

Encouraging Antibiotics Research Biotechs Have Plenty to GAIN

By Peter Winter

Monday, December 17, 2012

The FDA wants to hear from industry and other interested parties on what should constitute a "qualifying pathogen" that could trigger a range of incentives designed to encourage companies to develop new antibiotics targeting these designated pathogens.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription